Cedars-Sinai Heart Institute works with referring physicians to provide specialized treatment for adults with heart failure and cardiomyopathy.
The Institute's staff provides close patient monitoring by a dedicated heart failure nurse, as well as a referral to Cedars-Sinai's Preventive and Rehabilitative Cardiac Center for supervised, graded exercise programs.
Cedars-Sinai Heart Institute offers both established and experimental treatments for heart failure, including beta-blocker initiation and titration, clinical trials of vasopetidase inhibitors, ventricular pacing and new oral and intravenous inotropes (such as calcium sensitizers and new phosphodiesterase inhibitors).
For patients with end-stage heart failure who are candidates for cardiac transplantation, Cedars-Sinai surgeons may implant the HeartMate® left ventricular assist device (LVAD) to manage the mechanical function of the heart's left ventricle. The LVAD allows the patient additional time and improved health while waiting for a transplant.
Cedars-Sinai Heart Institute's diagnostic services for heart failure include:
- Blood and urine tests
- Cardiopulmonary exercise testing
- Magnetic resonance imaging (MRI)
- Nuclear cardiology
Innovative treatment options include:
An important part of the patient's treatment plan is the comprehensive education provided through the program on nutrition, diet, exercise and heart failure medications.
Cedars-Sinai Heart Institute is currently involved in clinical trials relating to heart failure. These research efforts are designed to explore new avenues for treatments to help individuals with heart failure.